Vagus stimulation. Mechanisms and current clinical importance in heart failure;Vagusstimulation. Mechanismen und momentaner klinischer Stellenwert bei der herzinsuffizienz

Herzschrittmachertherapie und Elektrophysiologie

Volumn 22, Issue 1, 2011, Pages 21-26

  Kuschyk, J ^a   Borggrefe, M ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Autonomous dysbalance; Electrical therapy; Heart failure; Left ventricle remodeling; Quality of life

Indexed keywords

CYTOKINE;

ANTIARRHYTHMIC ACTIVITY; CLINICAL ASSESSMENT; DISEASE SEVERITY; EXERCISE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE VARIABILITY; HUMAN; PATIENT SAFETY; PRESSORECEPTOR REFLEX; QUALITY OF LIFE; REVIEW; SYSTOLIC DYSFUNCTION; VAGUS NERVE STIMULATION;

CARDIAC RESYNCHRONIZATION THERAPY; HEART FAILURE; HUMANS; VAGUS NERVE;

EID: 79953290677     PISSN: 09387412     EISSN: 14351544     Source Type: Journal    
DOI: 10.1007/s00399-011-0119-0     Document Type: Review

References (25)

1. Baensch D, Groenefeld G (2010) Der Patient mit chronischer Herzinsuffizienz. Herzschrittmacherther Elektrophysiol 21:112-116
2. Ben-Menachem E (2001) Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol 18:415-418
3. De Ferrari GM, Crijns HJGM, Borggrefe M et al (2010) Chronic vagus nerve stimulation: a new and promising therapeutic approach for chronic heart failure. Eur Heart J (in press)
4. De Ferrari GM, Salvati P, Grossoni M et al (1993) Pharmacologic modulation of the autonomic nervous system in the prevention of sudden cardiac death. A study with propranolol, methacholine and oxotremorine in conscious dogs with a healed myocardial infarction. J Am Coll Cardiol 22:283-290 (Pubitemid 23189963)
5. De Ferrari GM, Sanzo A, Bertoletti A et al (2007) Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 50:2285-2290 (Pubitemid 350192103)
6. De Ferrari GM, Schwartz PJ (2011) Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. Heart Fail Rev (in press)
7. De Ferrari GM, Vanoli E et al (1991) Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with a healed myocardial infarction. Am J Physiol 261:H63-H69
8. La Rovere MT, Bigger JT Jr, Marcus FI et al (1998) Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 351:478-484 (Pubitemid 28070094)
9. Lechat P, Hulot JS, Escolano S et al (2002) Heart rate and cardiac rhythm relationship with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 103:1428-1433 (Pubitemid 32220636)
10. Li M, Zheng C, Sato T et al (2004) Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109:120-124 (Pubitemid 38056032)
11. Milby AH, Halpern CH, Baltuch GH (2008) Vagus nerve stimulation for epilepsy and depression. Neurotherapeutics 5:75-85 (Pubitemid 350299304)
12. Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS (2008) Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 118:863-871
13. Rastogi S, Mishra S, Ilsar I et al (2007) Chronic therapy with electric Vagus nerve stimulation normalizes mRNA and protein expression of connexin-40, -43 and -45 in left ventricular myocardium of dogs with heart failure (abstract). Circulation 116:II-218
14. Sabbah HN, Imai M, Zaretsky A et al (2007) Therapy with vagus nerve electrical stimulation combined with beta-blockade improves left ventricular systolic function in dogs with heart failure beyond that seen with betablockade alone (abstr). Eur J Heart Fail 6:114
15. Sabbah HN, Itamar I, Zaretsky A et al (2011) Vagus nerve stimulation in experimental heart failure. Heart Fail Rev (in press)
16. Sabbah HN, Shimoyama H, Kono T et al (1994) Effects of long-term monotherapy with enalapril, metoprolol and digoxin on the progression of left ventricular dysfunction and dilatation in dogs with reduced ejection fraction. Circulation 89:2852-2859 (Pubitemid 24173708)
17. Sabbah HN, Wang M, Jiang A et al (2010) Right vagus nerve stimulation improves left ventricular function in dogs with heart failure (abstr). J Am Coll Cardiol 55(Suppl): A1, E151
18. Schwartz PJ, De Ferrari GM, Sanzo A et al (2008) Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Fail 10:884-891
19. Schwartz PJ, Vanoli E, Stramba-Badiale M et al (1988) Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 78:969-979
20. Shuchman M (2007) Approving the vagus-nerve stimulator for depression. N Engl J Med 356:1604-1607
21. Swedberg K, Komajda M, Böhm M et al (2010) Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study. Lancet 376:875-885
22. Tracey KJ (2002) The inflammatory reflex. Nature 420:853-859
23. Vanoli E, De Ferrari GM, Stramba-Badiale M et al (1991) Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. Circ Res 68:1471-1481
24. Young JB, Abraham WT, Smith AL et al (2003) MIRACLE ICD Trial Investigators Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure. The MIRACLE ICD trial. JAMA 289:2685-2694 (Pubitemid 37430139)
25. Zhang Y, Popovic ZB, Bibevski S et al (2009) Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail 2:692-699